Paulette Haselhorst, PHARMD in Cabo Rojo, PR - Pharmacist

Paulette Haselhorst, PHARMD is a Pharmacist based in Cabo Rojo, Puerto Rico. Paulette Haselhorst is licensed to practice in Florida (license number PS042981) and her current practice location is Urb Colinas Del Mar, Cabo Rojo, Puerto Rico. She can be reached at her office (for appointments etc.) via phone at (787) 464-6583.

NPI number for Paulette Haselhorst is 1366075806 and her current mailing address is Po Box 3662, Mayaguez, Puerto Rico. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1366075806.

Contact Information

	Paulette Haselhorst, PHARMD
	Urb Colinas Del Mar, Cabo Rojo, PR 00623
	(787) 464-6583
	Not Available

Healthcare Provider's Profile

Full Name	Paulette Haselhorst
Gender	Female
Speciality	Pharmacist
Location	Urb Colinas Del Mar, Cabo Rojo, Puerto Rico
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1366075806
Provider Enumeration Date: 02/12/2020
Last Update Date: 02/12/2020

Medical Identifiers

Medical identifiers for Paulette Haselhorst such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1366075806	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	PS042981 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paulette Haselhorst is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paulette Haselhorst, PHARMD Po Box 3662, Mayaguez, PR 00681-3662 Ph: (787) 464-6583	Paulette Haselhorst, PHARMD Urb Colinas Del Mar, Cabo Rojo, PR 00623 Ph: (787) 464-6583

News Archive

FDA Advisory Committees vote against approval of Acurox NDA

Acura Pharmaceuticals, Inc. and King Pharmaceuticals®, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Life Support Drugs and Drug Safety and Risk Management Committees voted that they do not have enough evidence to support the approval of the New Drug Application (NDA) for Acurox® (oxycodone HCl and niacin) Tablets for the treatment of moderate to severe pain, considering the deterrent effects of niacin as well as the potential deterrent effects of the other features specific to Acurox®.

HHS announces awards to help states facilitate health information exchange and advance health IT

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced awards to help states facilitate health information exchange and advance health information technology (health IT). Funded by the American Recovery and Reinvestment Act of 2009, today's awards are part of the $2 billion effort to achieve widespread meaningful use of health IT and provide use of an electronic health record by every citizen by the year 2014.

Scientists discover new pathway to manipulate, maintain human ESCs in a "na-ve"

For years, researchers and patients have hoped that embryonic stem cells (ESCs)-capable of forming nearly any cell type in the body-could provide insight into numerous diseases perhaps even be used to treat them. Yet progress has been hampered by the inability to transfer research and tools from mouse ESC studies to their human counterparts, in part because human ESCs are "primed" and slightly less plastic than the mouse cells.

Possible overlap exists between inflammatory bowel disease and IBS

Research unveiled today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas suggests a possible overlap of symptoms of two prevalent GI disorders: irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) and further suggests a possible link between subtle GI tract inflammation and IBS symptoms-a link that is also the focus of the first systemic review of the literature on this topic and an editorial both published in this month's American Journal of Gastroenterology.

Taking HRT before the menopause may prevent heart disease

According to American researcher Jay Kaplan, taking the "Pill" before the menopause or starting hormone replacement therapy before menopausal symptoms begin could actually help prevent heart disease in women.

Pharmacist in Cabo Rojo, PR

Adriana Carolina Santiago Lopez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr 100 Km 6.6 Bo Miradero, Cabo Rojo, PR 00623 Phone: 787-808-5040
Pilar E Diaz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45 Munoz Rivera St, Cabo Rojo, PR 00623 Phone: 787-851-1250 Fax: 787-851-1250
Gloria Montalvo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr 102 Ave Pedro Albizu Campos, Centro Profesional Borinquen, Cabo Rojo, PR 00623 Phone: 787-458-8103
Ms. Fernando Luis Vega-hernandez Sr., BSPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45 Calle Munoz Rivera, Cabo Rojo, PR 00623 Phone: 787-851-1250
Dr. Linet Velez, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr 101 Km 15.8 Carr Interior, Urb. Los Prados, Cabo Rojo, PR 00622 Phone: 787-614-2756
Aalyah Stephanie Chaves, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Urbanizacion Mansiones Calle Monaco, C 33 Carretera 100, Cabo Rojo, PR 00623 Phone: 787-673-3814
Edwin Carles Julia, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Cond Danza Del Sol Apt 408, Bo Joyuda, Cabo Rojo, PR 00623 Phone: 787-637-0202

Paulette Haselhorst, PHARMD - Pharmacist in Cabo Rojo, PR